REPLIMUNE GROUP, INC. Earnings Per Share (Basic)
REPLIMUNE GROUP, INC. (REPL) reported Earnings Per Share (Basic) of -$0.72 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- REPLIMUNE GROUP, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.72.
- REPLIMUNE GROUP, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.77.
- REPLIMUNE GROUP, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.77.
- REPLIMUNE GROUP, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.90.
- REPLIMUNE GROUP, INC. earnings per share, basic for fiscal 2026 was -$3.38.
- REPLIMUNE GROUP, INC. earnings per share, basic for fiscal 2025 was -$3.07.
- REPLIMUNE GROUP, INC. earnings per share, basic for fiscal 2024 was -$3.24.
- REPLIMUNE GROUP, INC. earnings per share, basic for fiscal 2023 was -$2.99.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.72 10-Q · filed 2026-08-14 | -$1.49 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.25 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.16 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$1.54 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$2.44 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$3.38 10-K · filed 2026-06-29 |
| 2025-12-31 | -$0.77 10-Q · filed 2026-02-03 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-02-03 | -$2.62 10-Q · filed 2026-02-03 | -$3.44 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-09-30 | -$0.90 10-Q · filed 2025-11-06 | -$1.85 10-Q · filed 2025-11-06 | -$2.67 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.47 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$0.95 10-Q · filed 2026-08-14 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.56 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$3.25 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$2.29 derived: net income ÷ weighted average shares · filed 2026-06-29 | -$3.07 10-K · filed 2026-06-29 |
| 2024-12-31 | -$0.79 10-Q · filed 2026-02-03 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-02-03 | -$2.25 10-Q · filed 2026-02-03 | -$3.06 derived: net income ÷ weighted average shares · filed 2026-02-03 |
| 2024-09-30 | -$0.68 10-Q · filed 2025-11-06 | -$1.45 10-Q · filed 2025-11-06 | -$2.27 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$3.03 derived: net income ÷ weighted average shares · filed 2025-11-06 |
| 2024-06-30 | -$0.78 10-Q · filed 2025-08-07 | -$1.60 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$2.37 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$3.27 derived: net income ÷ weighted average shares · filed 2025-08-07 |
| 2024-03-31 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-05-22 | -$1.59 derived: net income ÷ weighted average shares · filed 2025-05-22 | -$2.49 derived: net income ÷ weighted average shares · filed 2025-05-22 | -$3.24 10-K · filed 2025-05-22 |
| 2023-12-31 | -$0.77 10-Q · filed 2025-02-12 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-02-12 | -$2.42 10-Q · filed 2025-02-12 | -$3.16 derived: net income ÷ weighted average shares · filed 2025-02-12 |
| 2023-09-30 | -$0.90 10-Q · filed 2024-11-12 | -$1.65 10-Q · filed 2024-11-12 | -$2.40 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$3.09 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.75 10-Q · filed 2024-08-08 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2.18 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2.96 derived: net income ÷ weighted average shares · filed 2024-08-08 |
| 2023-03-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2024-05-16 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-05-16 | -$2.22 derived: net income ÷ weighted average shares · filed 2024-05-16 | -$2.99 10-K · filed 2024-05-16 |
| 2022-12-31 | -$0.69 10-Q · filed 2024-02-08 | -$1.47 derived: net income ÷ weighted average shares · filed 2024-02-08 | -$2.25 10-Q · filed 2024-02-08 | -$2.86 derived: net income ÷ weighted average shares · filed 2024-02-08 |
| 2022-09-30 | -$0.79 10-Q · filed 2023-11-07 | -$1.57 10-Q · filed 2023-11-07 | -$2.17 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.74 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$0.78 10-Q · filed 2023-08-03 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$1.95 derived: net income ÷ weighted average shares · filed 2023-08-03 | -$2.52 derived: net income ÷ weighted average shares · filed 2023-08-03 |
| 2022-03-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-05-18 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-05-18 | -$1.73 derived: net income ÷ weighted average shares · filed 2023-05-18 | -$2.26 10-K · filed 2023-05-18 |
| 2021-12-31 | -$0.57 10-Q · filed 2023-02-09 | -$1.13 derived: net income ÷ weighted average shares · filed 2023-02-09 | -$1.66 10-Q · filed 2023-02-09 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-02-09 |
| 2021-09-30 | -$0.56 10-Q · filed 2022-11-03 | -$1.09 10-Q · filed 2022-11-03 | -$1.51 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.95 derived: net income ÷ weighted average shares · filed 2022-11-03 |
| 2021-06-30 | -$0.53 10-Q · filed 2022-08-04 | -$0.94 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$1.38 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$1.84 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-05-19 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-05-19 | -$1.31 derived: net income ÷ weighted average shares · filed 2022-05-19 | -$1.75 10-K · filed 2022-05-19 |
| 2020-12-31 | -$0.44 10-Q · filed 2022-02-03 | -$0.90 derived: net income ÷ weighted average shares · filed 2022-02-03 | -$1.34 10-Q · filed 2022-02-03 | |
| 2020-09-30 | -$0.46 10-Q · filed 2021-11-04 | -$0.90 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$0.44 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |